Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs targeted at expanding the horizons of cytokine-based immunotherapy, specifically for cancers where remedy solutions remain limited. Use the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Check out Our Pipeline https://financefeeds.com/anthony-scaramucci-sec-ripple-case/